key: cord-0878551-g1ydod5x
authors: Patel, Luv G.; Peck, Travis; Starr, Matthew R.; Ammar, Michael J.; Khan, M. Ali; Yonekawa, Yoshihiro; Klufas, Michael A.; Regillo, Carl D.; Ho, Allen C.; Xu, David
title: Clinical Presentation of Rhegmatogenous Retinal Detachment During the COVID-19 Pandemic: A Historical Cohort Study
date: 2020-10-13
journal: Ophthalmology
DOI: 10.1016/j.ophtha.2020.10.009
sha: 62f0636a7a03025749d8723c322a33b5463bb195
doc_id: 878551
cord_uid: g1ydod5x

OBJECTIVE: To investigate the effect of the COVID-19 pandemic on the clinical presentation of acute, primary rhegmatogenous retinal detachment (RRD). DESIGN: Single-center, consecutive case series with historical controls. SUBJECTS: Consecutive patients presenting with primary RRD in a 50-day period during the USA COVID-19 pandemic (March 9(th) - April 27(th), 2020) and the corresponding 50-day period in the previous year (March 4(th) - April 22(th), 2019). METHODS: The cohorts were compared to assess demographic variables and clinical presentations. Multivariate logistic regression was used to identify factors predictive of presenting macular attachment status. MAIN OUTCOME MEASURE: The primary outcome was the proportion of patients with macula-on RRD at presentation. Secondary outcomes included visual acuity (VA), duration of symptoms prior to presentation, proportion presenting within one day of symptom onset, and presence of primary proliferative vitreoretinopathy (PVR). RESULTS: Eighty-two patients were included in the 2020 cohort compared to 111 patients in the 2019 primary control cohort. Demographic factors were similar between the groups. Significantly fewer patients presented with macula-on RRD in the 2020 cohort (20/82 patients, 24.4%) than in 2019 (55/111 patients, 49.5%, p = 0.001). Patients in the 2020 cohort had worse median VA at presentation (LogMAR 1.00, Snellen 20/200 in 2020 versus LogMAR 0.48, Snellen 20/60 in 2019, p = 0.008), fewer patients presenting within one day of symptoms (16/80 patients [19.5%] in 2020 versus 41/106 patients [36.9%] in 2019, p = 0.005), and a greater proportion with primary PVR (11/82 patients [13.4%] in 2020 versus 5/111 patients [4.5%] in 2019, p = 0.03). In multivariate analysis, younger age (p = 0.03) and established patient status (p = 0.02) were independent predictors of macula-on status in the 2020 cohort. CONCLUSIONS: Patients with primary RRD during the 2020 COVID-19 pandemic were less likely to be macula-on and more likely to have delayed presentation, worse vision, and PVR.

Coronavirus disease 2019 (COVID-19) is the result of a zoonotic virus spread by human-69 to-human transmission and was declared a pandemic by the World Health Organization on 70

March 11 th , 2020. 1 In the United States, the pandemic has strained healthcare resources and 71 has led to stay-at-home orders with closure of non-essential activities, including non-urgent 72 healthcare services. 2 In addition to those patients directly infected, the outbreak has also 73 impacted patients seeking care for unrelated ( worse visual acuity and surgical outcomes. [8] [9] [10] [11] Prior studies have suggested a delay of 7 days 91 can lead to worse visual outcomes, while some recent studies have suggested that a delay in 92 even 3 days leads to worse visual acuity outcomes. 12 Detailed demographic, preoperative, and intra-operative data were collected from 116 electronic health record review. Race was self-identified with categories of "White or 117

Caucasian", "Black or African American", "Asian or Pacific Islander", "Native American or 118 Alaskan Native", "Decline to specify" or "Other". Patients' median regional income was used as 119 a quantitative surrogate for socioeconomic status, tabulated from the American Communities 120

Survey 2017 of median income by zip code. Patients were subdivided based on whether they 121 had previously established care with the practice. A patient was considered "established" if the 122 patient had previously been seen by the retina practice within a 3-year period prior to 123 presentation, or was otherwise deemed "new". The distance that patients lived from the site of 124 surgical repair was calculated based on the latitude and longitude difference between the 125 patients' zip code and Wills Eye Hospital. 126

The primary outcome was the proportion of patients presenting with macula-on RRD, as 127 (LogMAR) scale for all statistical analyses. An acuity of "count fingers" was converted to 2 and 140 "hand motion perception" was converted to 3 as previously described. 14 For comparison of 141 categorical variables between the two cohorts, including the primary outcome of macula status, 142 a two-tailed Fisher's Exact Test was used. Normality of the quantitative variables, LogMAR VA 143 and duration of symptoms, was assessed using the Shapiro-Wilk test. As both were found to be 144 non-normal, a Mann Whitney U test was utilized for comparison of distributions. Multivariate 145 logistic regression analysis was performed to assess for predictors of macula status controlling 146 for all available demographic factors: age, median regional income, established patient status, 147 gender, and race. A multivariate stepwise model was used to identify relevant demographic 148 variables with a probability to enter < 0.05 and a probability to remove > 0.10. A p value less 149 than 0.05 was considered statistically significant. There were no significant differences in presenting age, gender, proportion of patients 160 identifying as white, mean regional household income, established patient status and mean 161 geographic distance between the 2020, 2019, and 2018 cohort groups ( Table 1) In this study, we evaluated the demographic and presenting characteristics, time to 214 presentation, and demographic differences of acute RRD during the COVID-19 pandemic. We 215 found signs of delayed presentation and increased RRD chronicity. We observed a significant 216 decrease in the proportion of macula-on of patients presenting during the COVID-19 pandemic 217 as compared to a demographically similar cohort in the same period of time one year prior; this 218 control group (2019) was also validated by comparison with a corresponding control group 219 from the prior year (2018) to ensure an accurate control group was used in this study. 220

We selected RRD as an index disease for study, as its symptoms are considered urgent 221 and warrants prompt evaluation. In our study, the presence or absence of subfoveal fluid 222 (macular attachment status) was chosen as the primary outcome because it was consistently 223 documented, served as an objective measure across all patients, and often correlates with 224 visual outcome. 15 The presence of primary grade C PVR is another poor prognostic factor 225 associated with delayed presentation, and was also significantly greater during the COVID-19 226 pandemic. 16 Grade C PVR, which was consistently documented. Further work also needs to be done to 257 analyze the long-term follow-up and anatomic/functional outcomes between the cohorts, as 258 this was outside the scope of the current investigation. The generalizability of the study is also 259 unknown, as our findings may be unique to our local geographical area and patient population. 260

The specific age and racial demographic breakdown of our region may potentially limit its 261 generalizability to the US as whole. The incidence of COVID-19 has also affected different 262 localities and demographics with various intensities.

In our practice, there was no difference in timing of surgery between 2020 and prior 264 years after an RRD was diagnosed. None of the patients in our cohort had positive COVID-19 265 symptomology or positive testing, so COVID-19 illness was not expected to influence the time 266 to presentation. However, there were some differences in the outpatient evaluation of patients 267 in 2020. Patients were not allowed visitors, for example, and both providers and patients were 268 Table 2 . Presenting characteristics of rhegmatogenous retinal detachment during the 2020 COVID-19, 2019 primary control, and 2018 secondary control group. There was no difference in the presenting characteristics between the 2018 and 2019 controls. There was a significant decrease in macula-on presentation (P < 0.001), decrease in proportion of patients presenting within 1 day of symptoms (P = 0.005), and increase in the proportion of patients presenting with primary PVR (P = 0.03) in the 2020 cohort compared to the 2019 control. The median LogMAR VA was worse for the 2020 cohort compared with the 2019 control with a significant difference in distributions (P = 0.008). COVID-19 = Coronavirus disease 2019 LogMAR = logarithm of the minimum angle of resolution

COVID-19 situation reports

The COVID-19 Pandemic in the US: A Clinical Update

Impact of Coronavirus 302 Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care

ST-Segment Elevation Cardiac 305

Catheterization Laboratory Activations in the United States during COVID-19 Pandemic

Decline of acute coronary syndrome admissions in 309

Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral 310 damage

Impacto de la pandemia de COVID-19 sobre la 312 actividad asistencial en cardiología intervencionista en España

Delayed presentation of acute ischemic strokes 314 during the COVID-19 crisis

Socioeconomic status and delayed 316 presentation in rhegmatogenous retinal detachment

Primary Retinal Detachment Outcomes Study Report 318 Number 2: Phakic Retinal Detachment Outcomes

Long-term visual acuity and the duration of macular 320 detachment: findings from a prospective population-based study

Prognosis for central vision and anatomic 323 reattachment in rhegmatogenous retinal detachment with macula detached

Reductions in final visual acuity occur even within the 326 first 3 days after a macula-off retinal detachment

IMPACT OF DURATION OF MACULA-328 OFF RETINAL DETACHMENT ON VISUAL OUTCOME: A Systematic Review and Meta-analysis of 329 Literature

Proper method for calculating average visual acuity

Surgical failure following primary retinal detachment 333 surgery by vitrectomy: risk factors and functional outcomes

Clinical Variables Associated with 336 Failure of Retinal Detachment Repair: The European Vitreo-Retinal Society Retinal Detachment 337 Study Report Number 4

Patient ignorance is the main reason for 339 treatment delay in primary rhegmatogenous retinal detachment in The Netherlands

What made you wait so long? Delays in 342 presentation of retinal detachment: knowledge is related to an attached macula

The impact of COVID policies on acute ophthalmology 345 services-experiences from Moorfields Eye Hospital NHS Foundation Trust